Join us as Dr. John Majercak, Head of Antibody Discovery, will spotlight LAMPIRE’s cutting-edge methods in monoclonal antibody development. Dr. John Majercak will delve into our specialized antibody offerings, including Llama vHH nanobodies, Bovine ultra-long CDR3 Picobodies, and Rabbit Monoclonals, revealing the latest breakthroughs in antibody therapeutics.
TITLE: Sequence-Forward, Single B-cell Solutions by LAMPIRE for Monoclonal Antibody Discovery Across Multiple Species
DATE: Wednesday, May 14
TIME: 12:50 – 1:20 PM (Second Luncheon Session)